Lakewood-Amedex Biotherapeutics (LABT.US) fell to $8.34, down 3.58% intraday, with the decline accelerating within a 5-minute window.

The biopharmaceutical company has no recent material announcements on record; the intraday selloff appears driven by short-term sentiment and thin liquidity rather than fundamental catalysts, with market participants monitoring volume for signs of further pressure.